FDA Inspection 1245831 — American Red Cross Biomedical Services Northern New England Region

American Red Cross Biomedical Services Northern New England Region — FEI 1273026

The FDA completed an inspection of American Red Cross Biomedical Services Northern New England Region on July 31, 2024 in Burlington, VT. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 31, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Burlington, VT (United States)